Management and ownership · SANA PHARMA HOLDING AS
Owners
2 shareholders as of 31 December 2020.
HELSE ASTELECOM AS
| Owner | Org. no. | Shares | Share |
|---|---|---|---|
| HELSE AS | 50 | 50.0% | |
| TELECOM AS | 50 | 50.0% | |
| Total, all 2 | 100 | 100.0% | |
Source: the Tax Administration's Register of Shareholders as of 31 December 2020, read 31 Jul 2026. The register runs about a year behind.
The company owns
| Company | Org. no. | Share | Register year |
|---|---|---|---|
| HETE INVEST AS | 897 755 432 | 100.0% | 2020 |
| IMMUNOCORP CONSUMER HEALTH AS | 981 633 482 | 100.0% | 2020 |
| SANA PHARMA MANAGEMENT AS | 914 756 324 | 91.1% | 2020 |
| QUANTUM 1 AS | 919 368 209 | 49.0% | 2020 |
| CAMPUS HAMAR INVEST I AS | 918 052 178 | 15.0% | 2020 |
| GULLGRUVEN I AS | 920 031 404 | 7.0% | 2020 |
| CKG INVEST AS | 918 042 814 | 5.2% | 2020 |
| VESTKORRIDOREN EIENDOMSINVEST AS | 925 031 518 | 5.0% | 2020 |
| HELSFYR KONTORINVEST II AS | 921 563 051 | 4.2% | 2020 |
| LYSAKER PARK INVEST I AS | 917 367 604 | 3.7% | 2020 |
| PP11 INVEST AS | 920 123 597 | 2.7% | 2020 |
| TELEGRAFEN INVEST AS | 923 640 932 | 1.9% | 2020 |
| ML 33 INVEST AS | 916 495 463 | 0.8% | 2020 |
Source: the Tax Administration's Register of Shareholders, read 31 Jul 2026 · The whole group → · The whole portfolio →